by Lance Smith | Aug 12, 2019 | Study Scavenger Clinical Trial Recruitment Platform
The main purpose of a study pipeline is to illustrate the progress of a clinical study, from beginning to end. From the discovering of potential treatments to the application of said treatments, all the way to the filing process, there is ample information that must...by Lance Smith | Aug 12, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Elysium Health, Inc.,™ a life sciences company developing clinically validated health products based on aging research, today announced the initiation of a clinical trial at University of Exeter, UK to explore the effects of Basis™ and high-intensity interval training...by Lance Smith | Aug 8, 2019 | Study Scavenger Clinical Trial Recruitment Platform
89Bio Ltd. (89bio), a clinical-stage biopharmaceutical company, today announced that the first patients have been screened in its proof of concept Phase 1b/2a clinical trial evaluating its investigational product candidate, BIO89-100, a glycoPEGylated analog of...by Lance Smith | Aug 8, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Geron Corporation (Nasdaq: GERN) today announced the opening of patient screening and enrollment for the Phase 3 portion of IMerge to evaluate imetelstat, a first-in-class telomerase inhibitor, in lower risk myelodysplastic syndromes (MDS). “The start of the Phase 3...by Lance Smith | Aug 8, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Pharmaceutical companies could reduce the cost of drug development thanks to a new partnership that aims to scale the next generation of digital clinical trials. Expand Global technology company HCL Technologies (HCL) has teamed up with Oracle Health Sciences to help...by Lance Smith | Aug 8, 2019 | Study Scavenger Clinical Trial Recruitment Platform
-Bispecific Diabody Designed to Intercept B-Cell Mediated Autoimmune Diseases- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it has dosed...